Arcutis Biotherapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
55.33
|
|
Average Rating
|
4.63
|
|
# Strong Buys
|
5
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.67
|
-1.89
|
-0.22
|
-13.17%
|
|
2022-06-30
|
-1.43
|
-1.31
|
0.12
|
8.39%
|
|
2022-03-31
|
-1.50
|
-1.27
|
0.23
|
15.33%
|
|
2021-12-31
|
-1.49
|
-1.42
|
0.07
|
4.70%
|
|
2021-09-30
|
-1.15
|
-1.14
|
0.01
|
0.87%
|
|
2021-06-30
|
-0.90
|
-0.84
|
0.06
|
6.67%
|
|
2021-03-31
|
-0.96
|
-0.76
|
0.20
|
20.83%
|
|
2020-12-31
|
-0.88
|
-0.79
|
0.09
|
10.23%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-4.47
|
|
2021-12-31
|
-4.16
|
|
2020-12-31
|
-3.89
|
|
2019-12-31
|
-14.21
|